NCT04237103 Combination of Methotrexate and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo Status COMPLETED Phase PHASE2
NCT04043494 International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma Status RECRUITING Phase PHASE3
NCT03964090 Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib, and Rituximab (TEDDI-R) in Aggressive B-cell Lymphomas With Secondary Involvement of the Central Nervous System (CNS) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03959085 Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy Status RECRUITING Phase PHASE3
NCT03914625 A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03808610 Low-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or Refractory B- or T-Cell Acute Lymphoblastic Leukemia Status TERMINATED Phase PHASE1/PHASE2
NCT03779854 Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant Status RECRUITING Phase PHASE2
NCT03719105 Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma Status RECRUITING Phase EARLY_PHASE1
NCT03710772 Ibrutinib, Rituximab, Venetoclax, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03703271 Study of Hysteroscopic Repeat Curettage as the First-line Treatment in Low-risk Postmolar Gestational Trophoblastic Neoplasia Status RECRUITING Phase PHASE3
NCT03531073 Multicentre ObservatioNal Initiative in Treat to Target Outcomes in Psoriatic Arthritis Status COMPLETED Phase N/A
NCT03488225 Combination Chemotherapy and Inotuzumab Ozogamicin in Treating Patients With B Acute Lymphoblastic Leukemia Status TERMINATED Phase PHASE2
NCT03414502 Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response Status RECRUITING Phase PHASE3
NCT03286634 ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016 Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03263572 Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia Status RECRUITING Phase PHASE2
NCT03206671 Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03150693 Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia Status RECRUITING Phase PHASE3
NCT03147612 Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03117751 Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3